CDK4/6 Inhibitors in Melanoma: A Comprehensive Review

by Mattia Garutti, Giada Targato, Silvia Buriolla, Lorenza Palmero, Alessandro Marco Minisini, Fabio Puglisi
Published 2021-05-01

Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation

by Michele De Tursi, Mario Alberto Occhipinti, Vincenzo Di Noia, Pamela Pizzutilo, Giada Targato, Simona Scodes, Fabrizio Tabbò, Fausto Petrelli
Published 2020-07-01

Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer

by Lorenzo Gerratana, Lorenzo Gerratana, Debora Basile, Debora Basile, Alessandra Franzoni, Lorenzo Allegri, Davide Viotto, Carla Corvaja, Carla Corvaja, Lucia Bortot, Lucia Bortot, Elisa Bertoli, Elisa Bertoli, Silvia Buriolla, Silvia Buriolla, Giada Targato, Giada Targato, Lucia Da Ros, Stefania Russo, Marta Bonotto, Barbara Belletti, Gustavo Baldassarre, Giuseppe Damante, Fabio Puglisi, Fabio Puglisi
Published 2020-09-01